Company Data
InMed Pharmaceuticals Inc.
Ticker
INM
Current Price
$2.18 -3.11%
Market Cap
$2.6M
Price Target
Refer to Report
Volume
34.8K
52wk Range
$1.72 - $8.58
Overview
InMed Pharmaceuticals Inc is a Canada based pre-clinical stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based therapies combined with drug delivery systems. It is focused on the treatment of diseases including pain and inflammation, dermatology, Orofacial Pain, Glaucoma, ocular, CNS, respiratory, metabolic diseases, and others.